Coldstream Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.14M Buy
5,507
+714
+15% +$278K 0.04% 266
2025
Q1
$2.08M Buy
4,793
+876
+22% +$381K 0.04% 239
2024
Q4
$1.44M Sell
3,917
-269
-6% -$99.2K 0.03% 305
2024
Q3
$2.13M Buy
4,186
+490
+13% +$250K 0.05% 224
2024
Q2
$2M Buy
3,696
+53
+1% +$28.7K 0.05% 204
2024
Q1
$1.89M Buy
3,643
+172
+5% +$89.2K 0.05% 210
2023
Q4
$1.64M Buy
3,471
+23
+0.7% +$10.8K 0.05% 211
2023
Q3
$1.5M Sell
3,448
-106
-3% -$46.2K 0.05% 212
2023
Q2
$1.58M Sell
3,554
-177
-5% -$78.7K 0.05% 210
2023
Q1
$1.72M Sell
3,731
-116
-3% -$53.3K 0.06% 199
2022
Q4
$1.97M Buy
+3,847
New +$1.97M 0.07% 173
2022
Q2
$1.73M Buy
3,583
+567
+19% +$274K 0.07% 158
2022
Q1
$1.48M Sell
3,016
-195
-6% -$95.8K 0.05% 197
2021
Q4
$1.49M Buy
3,211
+1,984
+162% +$920K 0.05% 203
2021
Q3
$330K Sell
1,227
-231
-16% -$62.1K 0.02% 299
2021
Q2
$557K Buy
1,458
+32
+2% +$12.2K 0.02% 260
2021
Q1
$512K Buy
1,426
+129
+10% +$46.3K 0.03% 219
2020
Q4
$417K Buy
1,297
+313
+32% +$101K 0.03% 234
2020
Q3
$265K Buy
984
+118
+14% +$31.8K 0.02% 256
2020
Q2
$228K Buy
+866
New +$228K 0.02% 268
2020
Q1
Sell
-876
Closed -$265K 301
2019
Q4
$265K Sell
876
-69
-7% -$20.9K 0.02% 275
2019
Q3
$226K Sell
945
-84
-8% -$20.1K 0.02% 291
2019
Q2
$290K Sell
1,029
-39
-4% -$11K 0.02% 251
2019
Q1
$307K Buy
1,068
+112
+12% +$32.2K 0.03% 235
2018
Q4
$251K Buy
+956
New +$251K 0.02% 259